Fambrough D M
Physiol Rev. 1979 Jan;59(1):165-227. doi: 10.1152/physrev.1979.59.1.165.
An ACh receptor is the molecular entity that, in its native habitat, possesses the binding sites for ACh and all the other components required to generate the ion channels mediating the ACh response. Narrower definitions of an ACh receptor (as the binding site for ACh or the polypeptide chain that is folded to form the binding site) could lead to semantic arguments about receptor structure. Experimentally, ACh receptors are defined by their total function (when electrophysiological tests are used) or by ligand binding. There is no evidence that the ligand-binding portions of ACh receptors ever exist in vivo without the associated channel-forming mechanism and vice versa. Most data are consistent with the idea that detergent-solubilized glycoproteins retaining the ACh binding sites of the receptor also include the channel-forming components, although it appears that the mechanism is prone to denaturation or proteolytic damage. Studies of receptor-rich membranes and of solubilized receptor glycoprotein have not yet yielded a totally satisfactory image of receptor structure. Most evidence favors an ACh receptor composed of three or four different types of glycosylated polypeptide chains organized into a unit of aggregate molecular weight about 300,000--400,000 daltons. Plasma membranes are dynamic structures in two different ways. First, their constituent molecules are in rapid thermal motion and, when these molecules are not tethered to extramembranous structures or mired in large aggregates, they fairly rapidly change their position in the plane of the lipid bilayer. Second, all membrane components are continually being synthesized and degraded. Acetylcholine receptors participate in both aspects of this dynamism. In this review it is proposed that the number and the distribution of ACh receptors in skeletal muscle are controlled by modulation of receptor metabolism and modulation of associations between receptor molecules or between receptors and other, as yet unidentified, elements in neuromuscular junctions and at extrajunctional sites where receptors are clustered. The arrangements of receptors in skeletal muscle and the total number of receptors in skeletal muscle may be regulated by separate mechanisms. Clusters of ACh receptors apparently can form spontaneously in extrajunctional areas of denervated muscles and in tissue-cultured embryonic muscle. Such clusters may be positionally stable and the receptor molecules in them may be highly restricted in mobility. Nevertheless, these receptors have average lifetimes on the order of 20 h, just like the nonclustered, mobile extrajunctional receptors. Receptor clusters also form at sites of innervation. In the chick embryo the junctional receptor molecules remain short-lived. The metabolism of ACh receptors is highly regulated. The biosynthesis of receptors commences during myogenesis at about the time myogenic cells become competent to fuse. Later, biosynthesis is dramatically repressed by muscle activity and possibly by other factors...
乙酰胆碱受体是一种分子实体,在其天然环境中,它拥有乙酰胆碱的结合位点以及生成介导乙酰胆碱反应的离子通道所需的所有其他成分。对乙酰胆碱受体的狭义定义(如乙酰胆碱的结合位点或折叠形成结合位点的多肽链)可能会引发关于受体结构的语义争论。在实验中,乙酰胆碱受体是根据其整体功能(当使用电生理测试时)或配体结合来定义的。没有证据表明乙酰胆碱受体的配体结合部分在体内曾经在没有相关通道形成机制的情况下存在,反之亦然。大多数数据与这样的观点一致,即保留受体乙酰胆碱结合位点的去污剂溶解糖蛋白也包括通道形成成分,尽管似乎该机制容易发生变性或蛋白水解损伤。对富含受体的膜和溶解的受体糖蛋白的研究尚未得出关于受体结构的完全令人满意的图像。大多数证据支持乙酰胆碱受体由三种或四种不同类型的糖基化多肽链组成,这些多肽链组装成一个总分子量约为300,000 - 400,000道尔顿的聚集体单元。质膜在两种不同方式上是动态结构。首先,其组成分子处于快速的热运动中,当这些分子没有与膜外结构相连或陷入大聚集体中时,它们会相当迅速地在脂质双层平面内改变位置。其次,所有膜成分都在不断地合成和降解。乙酰胆碱受体参与了这种动态变化的两个方面。在这篇综述中,有人提出骨骼肌中乙酰胆碱受体的数量和分布是通过受体代谢的调节以及受体分子之间或受体与神经肌肉接头和受体聚集的接头外部位中其他尚未确定的元素之间的关联调节来控制的。骨骼肌中受体的排列和骨骼肌中受体的总数可能由不同的机制调节。乙酰胆碱受体簇显然可以在去神经肌肉的接头外区域和组织培养的胚胎肌肉中自发形成。这样的簇可能在位置上是稳定的,其中的受体分子在移动性上可能受到高度限制。然而,这些受体的平均寿命约为20小时,就像非簇状、可移动的接头外受体一样。受体簇也在神经支配部位形成。在鸡胚中,接头处的受体分子寿命较短。乙酰胆碱受体的代谢受到高度调节。受体的生物合成在肌生成过程中大约在肌原细胞有能力融合时开始。后来,生物合成受到肌肉活动以及可能其他因素的显著抑制……